Premium
Hyaluronic acid injection in the glans penis for the treatment of refractory premature ejaculation: A prospective, controlled study
Author(s) -
Shebl Salah E.,
Ali Saadelddin,
Shokr Mohammed
Publication year - 2021
Publication title -
andrologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.633
H-Index - 59
eISSN - 1439-0272
pISSN - 0303-4569
DOI - 10.1111/and.14084
Subject(s) - medicine , glans penis , premature ejaculation , glans , penis , sexual intercourse , ejaculation , hyaluronic acid , saline , prospective cohort study , surgery , refractory (planetary science) , erectile dysfunction , urology , anesthesia , population , anatomy , psychology , environmental health , psychoanalysis , physics , astrobiology
We aimed to demonstrate the safety and efficacy of hyaluronic acid (HA) injection in the glans penis for the treatment of persistent premature ejaculation (PE). Eighty patients with persistent PE were divided equally into two groups. In group A, patients underwent HA injection by four‐inlet injection technique, while in group B, patients were subjected to saline injection in glans penis by the same method as a control group. Patients were followed up for six months. At the end of follow‐up, the IELT significantly improved in the HA injection group, as compared to the baseline values and control group. The maximal glandular circumference significantly increased at the 1st, 3rd and 6th month of follow‐up. The rate of patient satisfaction with sexual intercourse was 64.9%, 70.3% and 78.4% at the 1st, 3rd and 6th month of follow‐up, respectively. Besides, the partner satisfaction with sexual intercourse was 54.1%, 48.6% and 59.5% at the 1st, 3rd and 6th month of follow‐up, respectively. In conclusion, HA injection may represent a promising treatment modality for persistent PE.